Curavit (Health Care, Pharmaceutical) — Funding, Investors & Signals 2026

Curavit

A digital-first CRO & Virtual Site for clinical research

Founded 2019

Boston, United States 27 employees Series A Total: $5.00M Health Care, Pharmaceutical

Curavit is a leader in the design and execution of decentralized clinical trials, with the slogan "Curavit is a Leader in the Design and Execution of Decentralized Clinical Trials." Founded in 2019 and headquartered in the United States, Curavit is the "First All-Virtual CRO," specializing in the design and execution of decentralized or "virtual" clinical trials. By leveraging emerging technologies in digital health, cloud computing, and data science, Curavit is able to recruit, engage, and monitor diverse patient populations from anywhere, eliminating the need for physical infrastructure and travel, thus increasing data quality. The company brings together leading researchers, enrolls previously untapped and underserved patient populations, and applies machine learning algorithms to health and social engagement information to recruit participants. The $5.00M Series A investment received on 14 November 2022 from investors including Osage Venture Partners, Royal Street Ventures, Narrow Gauge Ventures, Matt Wallach, and Clark Golestani demonstrates the market's confidence in Curavit's innovative approach to revolutionizing clinical trials within the Health Care and Pharmaceutical industries. With a central virtual site that supports remote monitoring and is always audit-ready, Curavit is poised to continue making significant strides in the field of decentralized clinical trials.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	••••••	5	•••• ••••	14 Nov 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

••••••

•••• ••••

14 Nov 2022

FAQ About Curavit

A digital-first CRO & Virtual Site for clinical research

Curavit was founded in 2019.

Curavit is headquartered in Boston, United States.

Curavit operates in the following industries: Health Care, Pharmaceutical.

Curavit has approximately 27 employees.

Curavit has completed 1 funding round, raising a total of $5.00M. The latest funding stage is Series A.

Top alternatives and competitors to Curavit include Halo Health Systems, TrialX, NODE.Health, Savics, Mango Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Curavit and Halo Health Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Curavit

General Information

Track Curavit

Discover More

About Curavit

Funding Rounds & Investors (1)

Curavit Alternatives & Competitors

FAQ About Curavit

Don't just browse. Track.